Soubeyrand Sébastien, Lau Paulina, Nikpay Majid, Ma Lijiang, Bjorkegren Johan L M, McPherson Ruth
Atherogenomics Laboratory (S.S., P.L., M.N., R.M.), University of Ottawa Heart Institute, Canada.
Department of Genetics and Genomic Sciences, Institute of Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, NY (L.M., J.L.M.B.).
Circ Genom Precis Med. 2024 Dec;17(6):e004674. doi: 10.1161/CIRCGEN.124.004674. Epub 2024 Dec 3.
Genome-wide association studies identified a 20-Kb region of chromosome 8 (8q24.13) associated with plasma lipids, hepatic steatosis, and risk for coronary artery disease. The region is proximal to , and given its well-established role in lipid regulation in animal models, TRIB1 has been proposed to mediate the contribution of the 8q24.13 locus to these traits. This region overlaps a gene encoding the primate-specific long noncoding RNA transcript / (-associated locus), but the contribution of TRIBAL to coronary artery disease risk remains untested.
Using recently available expression quantitative trait loci data and hepatocyte models, we further investigated this locus by Mendelian randomization analysis. Following antisense oligonucleotide targeting of TRIBAL, transcription array, quantitative reverse transcription polymerase chain reaction, and enrichment analyses were performed and effects on apoB and triglyceride secretion were determined.
Mendelian randomization analysis supports a causal relationship between genetically determined hepatic expression and markers of hepatic steatosis and coronary artery disease risk. By contrast, expression data sets did not support expression quantitative trait loci relationships between coronary artery disease-associated variants and . suppression reduced the expression of key regulators of triglyceride metabolism and bile acid synthesis. Enrichment analyses identified patterns consistent with impaired metabolic functions, including reduced triglyceride and cholesterol handling ability. Furthermore, suppression was associated with reduced hepatocyte secretion of triglycerides.
This work identifies as a gene bridging the genotype-phenotype relationship at the 8q24.13 locus with effects on genes regulating hepatocyte lipid metabolism and triglyceride secretion.
全基因组关联研究确定了8号染色体上一个20千碱基对的区域(8q24.13),该区域与血浆脂质、肝脂肪变性及冠状动脉疾病风险相关。该区域靠近TRIB1基因,鉴于其在动物模型脂质调节中已明确的作用,有人提出TRIB1介导8q24.13基因座对这些性状的影响。该区域与一个编码灵长类特异性长链非编码RNA转录本/(-相关基因座)的基因重叠,但TRIB1对冠状动脉疾病风险的影响仍未得到验证。
利用最近可得的表达定量性状基因座数据和肝细胞模型,我们通过孟德尔随机化分析进一步研究了该基因座。在对TRIB1进行反义寡核苷酸靶向之后,进行了转录阵列、定量逆转录聚合酶链反应及富集分析,并确定了对载脂蛋白B和甘油三酯分泌的影响。
孟德尔随机化分析支持遗传决定的肝脏表达与肝脂肪变性标志物及冠状动脉疾病风险之间存在因果关系。相比之下,表达数据集不支持冠状动脉疾病相关变异与之间的表达定量性状基因座关系。抑制作用降低了甘油三酯代谢和胆汁酸合成关键调节因子的表达。富集分析确定了与代谢功能受损一致的模式,包括甘油三酯和胆固醇处理能力降低。此外,抑制作用与肝细胞甘油三酯分泌减少有关。
这项研究确定TRIB1是一个在8q24.13基因座上架起基因型-表型关系桥梁的基因,对调节肝细胞脂质代谢和甘油三酯分泌的基因有影响。